Similar binding of 3H-ADTN and 3H-apomorphine to calf brain dopamine receptors
- PMID: 456412
- DOI: 10.1016/0014-2999(79)90385-6
Similar binding of 3H-ADTN and 3H-apomorphine to calf brain dopamine receptors
Abstract
The binding of 3H(+/-)-ADTN (of high specific activity; 7.6 Ci/mmole) to homogenates of calf striatum was investigated. The dissociation constant (KD) for the specific, saturable binding of 3H-(+/-)-ADTN was 1 nM and the density of specific sites was 100 fmoles/mg protein. The IC50 values (nM concentrations inhibiting specific binding by 50%) were 0.9 for (+/-)-N-propyl-norapomorphine, 3.0 for dopamine, 7 for (--)-adrenaline, 60 for (--)-noradrenaline and 4000 for isoproterenol, a series of potencies compatible with properties for a dopaminergic site. The (+)-enantiomer of ADTN was 10 times more potent than (--)-ADTN in competing for 3H-(+/-)-ADTN, while the (--)-enantiomer of 5-OH-dipropyl-ATN was 40 times more potent than the (+)-isomer. The IC50 values for various agonists against 3H-(+/-)-ADTN were similar to those against 3H-apomorphine or 3H-dopamine in the calf striatum. A comparison of these 3H-(+/-)-ADTN data to those for 3H-spiperone suggests that the two 3H-ligands label different receptor sites.
Similar articles
-
Striatal binding of 2-amino-6,7-[3H]dihydroxy-1,2,3,4-tetrahydronaphthalene to two dopaminergic sites distinguished by their low and high affinity for neuroleptics.J Neurosci. 1982 Jul;2(7):895-906. doi: 10.1523/JNEUROSCI.02-07-00895.1982. J Neurosci. 1982. PMID: 6124583 Free PMC article.
-
Properties of dopamine agonist and antagonist binding sites in mammalian retina.Brain Res. 1980 Aug 4;194(2):403-18. doi: 10.1016/0006-8993(80)91221-4. Brain Res. 1980. PMID: 6770965
-
Species variation in dopamine receptor binding.Eur J Pharmacol. 1979 Nov 23;60(1):55-66. doi: 10.1016/0014-2999(79)90052-9. Eur J Pharmacol. 1979. PMID: 520417
-
Identification of dopamine "D3" and "D4" binding sites, labelled with [3H]2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalene, as high agonist affinity states of the D1 and D2 dopamine receptors, respectively.J Neurochem. 1986 Apr;46(4):1058-67. doi: 10.1111/j.1471-4159.1986.tb00618.x. J Neurochem. 1986. PMID: 2936868
-
[3H]dopamine labeling of D3 dopaminergic sites in human, rat, and calf brain.J Neurochem. 1982 Nov;39(5):1363-73. doi: 10.1111/j.1471-4159.1982.tb12579.x. J Neurochem. 1982. PMID: 7119802
Cited by
-
A review of the discovery, pharmacological characterization, and behavioral effects of the dopamine D2-like receptor antagonist eticlopride.CNS Neurosci Ther. 2008 Fall;14(3):248-62. doi: 10.1111/j.1755-5949.2008.00047.x. CNS Neurosci Ther. 2008. PMID: 18801115 Free PMC article. Review.
-
Interactions of isamoltane (CGP 361A), an anxiolytic phenoxypropanolamine derivative, with 5-HT1 receptor subtypes in the rat brain.Naunyn Schmiedebergs Arch Pharmacol. 1988 Jun;337(6):609-20. doi: 10.1007/BF00175785. Naunyn Schmiedebergs Arch Pharmacol. 1988. PMID: 2905765
-
Binding of 3H-ADTN, a dopamine agonist, to membranes of the bovine retina.Cell Mol Neurobiol. 1981 Jun;1(2):167-74. doi: 10.1007/BF00710717. Cell Mol Neurobiol. 1981. PMID: 7346167 Free PMC article.
-
[3H]2-amino-6,7-dihydroxy-1,2,3,4-tetrahydronaphthalen (ADTN). Regional distribution and in vivo binding after acute and chronic drug treatment.Neurochem Res. 1980 Jun;5(6):641-51. doi: 10.1007/BF00964785. Neurochem Res. 1980. PMID: 7402434
-
Functional reconstitution of rat striatal dopamine agonist receptors into artificial lipid bimolecular membranes.Biophys J. 1984 Jan;45(1):22-3. doi: 10.1016/S0006-3495(84)84093-X. Biophys J. 1984. PMID: 19431550 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources